- Home
- NWFL vs OKUR Comparison
NWFL vs OKUR Comparison
Compare NWFL & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- OKUR
- Stock Information
- Founded
- NWFL 1870
- OKUR 2011
- Country
- NWFL United States
- OKUR United States
- Employees
- NWFL 265
- OKUR N/A
- Industry
- NWFL Major Banks
- OKUR
- Sector
- NWFL Finance
- OKUR
- Exchange
- NWFL Nasdaq
- OKUR NYSE
- Market Cap
- NWFL 260.8M
- OKUR 234.2M
- IPO Year
- NWFL 1998
- OKUR N/A
- Fundamental
- Price
- NWFL $31.63
- OKUR $17.29
- Analyst Decision
- NWFL
- OKUR Strong Buy
- Analyst Count
- NWFL 0
- OKUR 2
- Target Price
- NWFL N/A
- OKUR $37.50
- AVG Volume (30 Days)
- NWFL 8.2K
- OKUR 63.8K
- Earning Date
- NWFL 10-28-2024
- OKUR 11-07-2024
- Dividend Yield
- NWFL 3.73%
- OKUR N/A
- EPS Growth
- NWFL N/A
- OKUR N/A
- EPS
- NWFL 1.59
- OKUR N/A
- Revenue
- NWFL $62,305,000.00
- OKUR N/A
- Revenue This Year
- NWFL N/A
- OKUR N/A
- Revenue Next Year
- NWFL N/A
- OKUR N/A
- P/E Ratio
- NWFL $20.24
- OKUR N/A
- Revenue Growth
- NWFL N/A
- OKUR N/A
- 52 Week Low
- NWFL $23.50
- OKUR $9.80
- 52 Week High
- NWFL $34.50
- OKUR $77.60
- Technical
- Relative Strength Index (RSI)
- NWFL 62.95
- OKUR N/A
- Support Level
- NWFL $31.11
- OKUR N/A
- Resistance Level
- NWFL $32.20
- OKUR N/A
- Average True Range (ATR)
- NWFL 1.02
- OKUR 0.00
- MACD
- NWFL 0.32
- OKUR 0.00
- Stochastic Oscillator
- NWFL 61.22
- OKUR 0.00
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.